T. Rowe Price Associates’s Axcelis ACLS Stock Holding History

T. Rowe Price Associates’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33.7M	Sell	362,202 -20,854	-5%	-$1.85M	﹤0.01%	895
2025 Q4	$30.8M	Sell	383,056 -149,052	-28%	-$12.5M	﹤0.01%	951
2025 Q3	$52M	Buy	532,108 +2,965	+0.6%	+$239K	0.01%	802
2025 Q2	$36.9M	Buy	529,143 +2,721	+0.5%	+$155K	﹤0.01%	815
2025 Q1	$26.1M	Buy	526,422 +2,053	+0.4%	+$130K	﹤0.01%	889
2024 Q4	$36.6M	Sell	524,369 -2,487	-0.5%	-$207K	﹤0.01%	846
2024 Q3	$55.2M	Sell	526,856 -4,274	-0.8%	-$500K	0.01%	731
2024 Q2	$75.5M	Buy	531,130 +67,992	+15%	+$7.84M	0.01%	604
2024 Q1	$51.6M	Sell	463,138 -386	-0.1%	-$46K	0.01%	722
2023 Q4	$60.1M	Buy	463,524 +24,549	+6%	+$3.38M	0.01%	650
2023 Q3	$71.6M	Sell	438,975 -50,711	-10%	-$8.92M	0.01%	583
2023 Q2	$89.8M	Sell	489,686 -25,741	-5%	-$3.71M	0.01%	550
2023 Q1	$68.7M	Sell	515,427 -2,724	-0.5%	-$320K	0.01%	598
2022 Q4	$41.1M	Buy	518,151 +58,055	+13%	+$4.09M	0.01%	713
2022 Q3	$27.9M	Buy	460,096 +3,512	+0.8%	+$227K	﹤0.01%	811
2022 Q2	$25M	Buy	456,584 +85,203	+23%	+$4.94M	﹤0.01%	1113
2022 Q1	$28.1M	Buy	+371,381	New	+$25.4M	﹤0.01%	1142
2020 Q4	–	Sell	-14,032	Closed	-$309K	–	2664
2020 Q3	$309K	Sell	14,032 -7,000	-33%	-$178K	﹤0.01%	2274
2020 Q2	$586K	Sell	21,032 -7,022	-25%	-$171K	﹤0.01%	1990
2020 Q1	$514K	Sell	28,054 -3,857	-12%	-$89.6K	﹤0.01%	1982
2019 Q4	$769K	Buy	31,911 +1,265	+4%	+$26.6K	﹤0.01%	1996
2019 Q3	$524K	Buy	30,646 +134	+0.4%	+$2.14K	﹤0.01%	2076
2019 Q2	$459K	Buy	30,512 +100	+0.3%	+$1.79K	﹤0.01%	2141
2019 Q1	$612K	Buy	30,412 +100	+0.3%	+$2.03K	﹤0.01%	2046
2018 Q4	$540K	Buy	30,312 +9,664	+47%	+$172K	﹤0.01%	2050
2018 Q3	$406K	Buy	20,648 +196	+1%	+$4.04K	﹤0.01%	2235
2018 Q2	$405K	Buy	20,452 +34	+0.2%	+$748	﹤0.01%	2237
2018 Q1	$502K	Buy	20,418 +9,659	+90%	+$254K	﹤0.01%	2086
2017 Q4	$309K	Sell	10,759 -4,800	-31%	-$151K	﹤0.01%	2270
2017 Q3	$426K	Hold	15,559	–	–	﹤0.01%	2150
2017 Q2	$326K	Buy	15,559 +6	+0%	+$127	﹤0.01%	2216
2017 Q1	$292K	Hold	15,553	–	–	﹤0.01%	2271
2016 Q4	$226K	Hold	15,553	–	–	﹤0.01%	2347
2016 Q3	$207K	Sell	15,553 -1	-0%	-$12	﹤0.01%	2343
2016 Q2	$167K	Hold	15,554	–	–	﹤0.01%	2365
2016 Q1	$174K	Hold	15,554	–	–	﹤0.01%	2317
2015 Q4	$161K	Buy	15,554 +75	+0.5%	+$797	﹤0.01%	2348
2015 Q3	$165K	Hold	15,479	–	–	﹤0.01%	2326
2015 Q2	$183K	Hold	15,479	–	–	﹤0.01%	2369
2015 Q1	$147K	Hold	15,479	–	–	﹤0.01%	2421
2014 Q4	$158K	Hold	15,479	–	–	﹤0.01%	2405
2014 Q3	$123K	Hold	15,479	–	–	﹤0.01%	2442
2014 Q2	$124K	Hold	15,479	–	–	﹤0.01%	2442
2014 Q1	$133K	Hold	15,479	–	–	﹤0.01%	2400
2013 Q4	$151K	Hold	15,479	–	–	﹤0.01%	2366
2013 Q3	$131K	Buy	15,479 +8,275	+115%	+$67.1K	﹤0.01%	2350
2013 Q2	$52K	Buy	+7,204	New	+$41.8K	﹤0.01%	2394

Other funds holding ACLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Associates's ACLS Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Axcelis (ACLS) stake by 5.4% in Q1 2026, selling an estimated $1.85M and leaving 362,202 shares worth $33.7M. The position accounts for ﹤0.01% of the portfolio, ranked #895.

T. Rowe Price Associates first reported a position in ACLS in Q2 2013 and has held it in 47 quarters since. The position peaked at $89.8M in Q2 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

T. Rowe Price Associates held 362,202 shares of Axcelis worth $33.7M as of Q1 2026.
T. Rowe Price Associates sold 20,854 Axcelis shares in Q1 2026, an estimated $1.85M.
Axcelis made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #895 holding.
T. Rowe Price Associates first reported a position in Axcelis in Q2 2013 and has held it in 47 quarters since.
T. Rowe Price Associates's Axcelis position peaked at $89.8M in Q2 2023.
377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.